Renalytix Plc (AIM:RENX)
6.75
0.00 (0.00%)
At close: Dec 5, 2025
Renalytix Market Cap
Renalytix has a market cap or net worth of 29.50 million as of December 5, 2025. Its market cap has increased by 22.85% in one year.
Market Cap
29.50M
Enterprise Value
32.86M
Revenue
2.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.75
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 29.50M, a decrease of -54.32%. That is a compound annual growth rate of -10.47%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.56B |
| GSK plc | 73.29B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.45B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |